Mylan N.V. Credit Rating

Usuarios Registrados

Registro para acceso total permitido. Su contraseña es sensible a mayúsculas y minúsculas.

Nombre de Usuario:

Contraseña:

Ingresar automáticamente en mi próxima visita

Iniciar sesión

¿Olvidó su Nombre de Usuario o Contraseña?

¿No se ha registrado?

Regístrese ahora para tener acceso GRATUITO a:

Calificaciones de Emisor.

Calificaciones de más de 170,000 instrumentos de corporativos, gobiernos y finanzas estructuradas.

Calendario de Eventos.

Información de cursos de capacitación, seminarios y teleconferencias.

Listas de Calificaciones en Observación.

Listas de emisores en revisión para cambios de calificación.

Metodologías de Calificación.

Marcos descriptivos del sustento de las calificaciones de Moody's.

Resultados 1 - 40 de 40

Página 1 de 1 Next

Filtrar por:

Fecha	Tipo de Informe	Title	Source
05 Oct 2023	Rating Action	Moody's affirms Viatris' Baa3 rating; outlook remains stable	Moody's Investors Service
27 Jul 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
07 Nov 2022	Announcement	Moody's: Viatris strategic initiatives support credit profile but have execution risk	Moody's Investors Service
04 Oct 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
10 Nov 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Viatris Inc.	Moody's Investors Service
22 Feb 2021	Announcement	Moody's: Headwinds including COVID reduce Viatris' ability to weather potential future setbacks - a credit negative	Moody's Investors Service
22 Feb 2021	Issuer Comment	Viatris Inc.: Headwinds including COVID reduce Viatris' ability to weather potential future setbacks - a credit negative	Moody's Investors Service
15 Dec 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Viatris Inc.	Moody's Investors Service
14 Dec 2020	Rating Action	Moody's assigns Prime-3 short-term rating to Viatris' commercial paper program	Moody's Investors Service
15 Jun 2020	Announcement	Moody's: Upcoming debt financing brings Mylan/Upjohn one step closer to Viatris creation	Moody's Investors Service
31 Mar 2020	Credit Opinion	Mylan N.V.: Update to credit analysis	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Mylan N.V.	Moody's Investors Service
30 Jul 2019	Issuer In-Depth	Mylan N.V.: Merger with Pfizer's Upjohn is credit positive but will present longer-term challenges for growth	Moody's Investors Service
29 Jul 2019	Rating Action	Moody's affirms Mylan's Baa3 ratings; outlook stable	Moody's Investors Service
08 Mar 2019	Credit Opinion	Mylan N.V.: Update following ratings affirmation at Baa3	Moody's Investors Service
01 Mar 2019	Rating Action	Moody's affirms Mylan's ratings; stable outlook	Moody's Investors Service
15 Feb 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Mylan N.V.	Moody's Investors Service
31 Jan 2019	Announcement	Moody's says FDA approval of generic Advair is credit positive for Mylan	Moody's Investors Service
31 Jan 2019	Issuer Comment	Mylan N.V.: Approval of generic version of Advair is credit positive for Mylan	Moody's Investors Service
31 Jul 2018	Rating Action	Moody's assigns Prime-3 rating to Mylan Inc.'s new CP program	Moody's Investors Service
27 Jun 2018	Issuer In-Depth	Mylan N.V.: Deleveraging path is mostly clear, but highly dependent on successful launches of generic Advair and other copycat drugs	Moody's Investors Service
21 Jun 2018	Credit Opinion	Mylan N.V.: Update to credit analysis - strong pipeline and cash flow help offset ongoing drug price pressures	Moody's Investors Service
16 May 2018	Rating Action	Moody's assigns Baa3 to Mylan's Euro offering	Moody's Investors Service
28 Mar 2018	Rating Action	Moody's assigns Baa3 to Mylan's offering	Moody's Investors Service
09 Oct 2017	Issuer Comment	Approval for Generic Copaxone Is Positive for Mylan and Negative for Teva	Moody's Investors Service
04 Oct 2017	Announcement	Moody's says approvals of generic versions of Copaxone are a credit positive for Mylan and a credit negative for Teva	Moody's Investors Service
04 Oct 2017	Sector Comment	Mylan N.V. and Teva Pharmaceutical Industries Ltd : Approvals of generic versions of Copaxone are credit positive for Mylan and negative for Teva	Moody's Investors Service
21 Aug 2017	Issuer Comment	Mylan Swallows another Bitter Pill with EpiPen Settlement	Moody's Investors Service
09 Aug 2017	Announcement	Moody's: Drug approval delays and pressure in US generics segment are credit negative for Mylan	Moody's Investors Service
09 Aug 2017	Issuer Comment	Mylan N.V.: Drug approval delays and pricing pressure in US generics segment are credit negative for Mylan	Moody's Investors Service
21 Jun 2017	Credit Opinion	Mylan N.V.: Update to Discussion of Key Credit Factors	Moody's Investors Service
09 Jun 2017	Rating Action	Moody's assigns Prime-3 rating to Mylan's new CP program	Moody's Investors Service
17 May 2017	Rating Action	Moody's assigns Baa3 to Mylan's euro notes offering; stable outlook	Moody's Investors Service
17 Nov 2016	Credit Opinion	Mylan N.V.: Update to Discussion of Key Credit Factors	Moody's Investors Service
15 Nov 2016	Rating Action	Moody's assigns Baa3 to Mylan's notes offering; stable outlook	Moody's Investors Service
10 Oct 2016	Announcement	Moody's: Mylan's EpiPen settlement is credit negative; ratings unaffected	Moody's Investors Service
10 Oct 2016	Issuer Comment	Mylan N.V.: EpiPen settlement is credit negative; ratings unaffected	Moody's Investors Service
31 May 2016	Rating Action	Moody's assigns Baa3 to Mylan's notes offering	Moody's Investors Service
11 Feb 2016	Rating Action	Moody's affirms Mylan's Baa3; outlook stable	Moody's Investors Service
04 Dec 2015	Rating Action	Moody's assigns Baa3 to Mylan's notes offering	Moody's Investors Service

Resultados 1 - 40 de 40

Página 1 de 1 Next

Informes & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

¿No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: